Galileo Research Facts No. 159: Can Galileo Therapy be used even under intense Chemotherapy in Leukemia?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 159: Can Galileo Therapy be used even under intense Chemotherapy in Leukemia?

Posted by
This safety study investigated the effects of Galileo Therapy during intense chemotherapy in Leukemia. Galileo Therapy was compared to cycling ergometer training (20 min., 18-25Hz, pos. 3-4, 120° squat, 3/week, 2 weeks). The Galileo group showed significant muscle function improvements compared to the ergometer group with in Chair-rise power (+4%), jump height (+12%) as well as timed up & go test (TUG, +19%)...
Continue reading
Galileo Research Facts No. 132: Can Galileo Therapy increase muscle power and decrease fall risk in Multiple Sclerosis (MS) patients?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 132: Can Galileo Therapy increase muscle power and decrease fall risk in Multiple Sclerosis (MS) patients?

Posted by
This pilot study reported the effects of Galileo Therapy on fall risk and muscle power in MS (multiple sclerosis) patients (20Hz, pos. 1.5, slightly flexed legs (20°), 5*1 min., 3/week, 8 weeks). Just 5 minutes Galileo Therapy 3 times per week showed decreased fall-risk and significantly improved balance (+12%), muscle function and muscle Power (+12%) as well as knee torque at flexor (+12) and extensor (15%)...
Continue reading
16 Sep
GRFS, Therapy

Galileo Research Facts No. 67: Can 5 minutes Galileo Therapy increase brain activity and mobility in stroke patients?

Posted by
This study evaluated the effects of Galilee Therapy on brain function (oxygenated Hemoglobin) and mobility in chronic stroke patients (Galileo Delta tilt table, 60° tilt, 20Hz, pos. 2, 5 min.). The Galileo groups showed more significant effects on mobility like the timed up & go test (+17%). Galileo Therapy also caused an increase of brain activity (Hemoglobin) with an increase of 600% directly after the Galileo Therapy...
Continue reading